Chronic Pancreatitis and Pancreatic Cancer: Prediction and Mechanism

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 11 SUPPL., 2009, Pages

  Shimosegawa, Tooru ^a   Kume, Kiyoshi ^a   Satoh, Kennichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL14 CHEMOKINE; DIMETHYLBENZ[A]ANTHRACENE; K RAS PROTEIN; PROTEIN P53; PROTEIN SPINK1; SERINE; SMAD4 PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CELL ACTIVATION; CELL CULTURE; CELL INTERACTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; GENE MUTATION; GENETIC DIFFERENCE; HUMAN; NONHUMAN; PANCREAS CANCER; PANCREAS STONE; PANCREATICODUODENECTOMY; PATHOGENESIS; PROGNOSIS; STELLATE CELL;

ADULT; AMINO ACID SUBSTITUTION; ANIMALS; CARRIER PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; GENE FREQUENCY; HUMANS; MICE; MIDDLE AGED; MUTATION, MISSENSE; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; POINT MUTATION; POLYMORPHISM, GENETIC; XYLENES;

EID: 71849117506     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.07.042     Document Type: Article

References (40)

1. Otsuki M., Tashiro M., Nishimori I., et al. Epidemiological survey of chronic pancreatitis in Japan [in Japanese]. Annual report of the Research Committee of Intractable Pancreatic Diseases (2005) 146-150
2. Otsuki M., and Tashiro M. Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases. Intern Med 46 (2007) 109-113
3. Otsuki M., and Fujino Y. Annual report of the Research Committee of Intractable Pancreatic Diseases [in Japanese] (2005) 153-157
4. Masamune A., Mizutamari H., Kume K., et al. Hereditary pancreatitis as the premalignant disease: a Japanese case of pancreatic cancer involving the SPINK1 gene mutation N34S. Pancreas 28 (2004) 305-310
5. Lowenfels A.B., Maisonneuve P., Cavallini G., et al. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328 (1993) 1433-1437
6. Whitcomb D.C., and Pogue-Geile K. Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 31 (2002) 663-678
7. Almoguera C., Shibata D., Forrester K., et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53 (1988) 549-554
8. Hruban R.H., Goggins M., Parsons J., et al. Progression model for pancreatic cancer. Clin Cancer Res 6 (2000) 2969-2972
9. Hamada S., Satoh K., Hirota M., et al. Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line. J Cell Physiol 213 (2007) 768-774
10. Wente M.N., Mayer C., Gaida M.M., et al. CXCL14 expression and potential function in pancreatic cancer. Cancer Lett 259 (2008) 209-217
11. Weichert W., Boehm M., Gekeler V., et al. High expression of RelA/p65 is associated with activation of nuclearfactor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer 97 (2007) 523-530
12. Pilarsky C., Ammerpohl O., Sipos B., et al. Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling. J Cell Mol Med 6B (2008) 2823-2835
13. Satoh K., Shimosegawa T., Moriizumi S., et al. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas. Pancreas 12 (1996) 362-368
14. Baud V., and Karin M. Is NF-kappaB a good target for cancer therapy?. Hopes and pitfalls. Nat Rev Drug Discov 8 (2009) 33-40
15. Kimura K., Satoh K., Kanno A., et al. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci 98 (2007) 155-162
16. Hruban R.H., Adsay N.V., Albores-Saavedra J., et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66 (2006) 95-106
17. Maitra A., Adsay N.V., Argani P., et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16 (2003) 902-912
18. Miyamoto Y., Maitra A., Ghosh B., et al. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3 (2003) 565-576
19. Ahlgren U., Jonsson J., and Edlund H. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122 (1996) 1409-1416
20. Sharma A., Zangen D.H., Reitz P., et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48 (1999) 507-513
21. Vonlaufen A., Joshi S., Qu C., et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 68 (2008) 2085-2093
22. Masamune A., and Shimosegawa T. Signal transduction in pancreatic stellate cells. J Gastroenterol 44 (2009) 249-260
23. Apte M.V., Haber P.S., Applegate T.L., et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43 (1998) 128-133
24. Furukawa T., Duguid W.P., Rosenberg L., et al. Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus. Am J Pathol 148 (1996) 1763-1770
25. Masamune A., Kikuta K., Watanabe T., et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 58 (2009) 550-559
26. Ishiwata T., Friess H., Büchler M.W., et al. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 153 (1998) 213-222
27. Weber D., Klomp H.J., Czubayko F., et al. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth. Cancer Res 60 (2000) 5284-5288
28. Vishwanatha J.K., Chiang Y., Kumble K.D., et al. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14 (1993) 2575-2579
29. Frick V.O., Rubie C., Wagner M., et al. Enhanced ENA-78 and IL-8 expression in patients with malignant pancreatic diseases. Pancreatology 8 (2008) 488-497
30. Narla G., DiFeo A., Yao S., et al. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res 65 (2005) 5761-5768
31. Matsuo Y., Ochi N., Sawai H., et al. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 124 (2009) 853-861
32. Schlierf B., Friedrich R.P., Roerig P., et al. Expression of SoxE and SoxD genes in human gliomas. Neuropathol Appl Neurobiol 33 (2007) 621-630
33. Chen Y., Guo Y., Ge X., et al. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. Biochem Biophys Res Commun 340 (2006) 758-766
34. Otto T., Horn S., Brockmann M., et al. Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 15 (2009) 67-78
35. Krajewska M., Kim H., Shin E., et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 11 (2005) 5462-5471
36. Liu W., Cheng S., Asa S.L., et al. The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 68 (2008) 8104-8112
37. Andrew A.S., Gui J., Sanderson A.C., et al. Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet 125 (2009) 527-539
38. Cassar L., Li H., Pinto A.R., et al. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res 68 (2008) 9157-9166
39. Blum D.L., Koyama T., M'koma A.E., et al. Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy. Clin Cancer Res 14 (2008) 7790-7791
40. Ordway J.M., Bedell J.A., Citek R.W., et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 27 (2006) 2409-2423